|
HY-125286-1mg
|
MedChemexpress LLC
|
AB-680 [CAS 2105904-82-1]
|
|
Cancer-programmed cell death
|
|
|
HY-125286-10mg
|
MedChemexpress LLC
|
AB-680 [CAS 2105904-82-1]
|
|
Cancer-programmed cell death
|
|
|
HY-125286-100mg
|
MedChemexpress LLC
|
AB-680 [CAS 2105904-82-1]
|
|
Cancer-programmed cell death
|
|
|
HY-125286-25mg
|
MedChemexpress LLC
|
AB-680 [CAS 2105904-82-1]
|
|
Cancer-programmed cell death
|
|
|
HY-125286-5mg
|
MedChemexpress LLC
|
AB-680 [CAS 2105904-82-1]
|
|
Cancer-programmed cell death
|
|
|
HY-125286-50mg
|
MedChemexpress LLC
|
AB-680 [CAS 2105904-82-1]
|
|
Cancer-programmed cell death
|
|
|
HY-125286-1mL
|
MedChemexpress LLC
|
AB-680 [CAS 2105904-82-1] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-N0233-1mg
|
MedChemexpress LLC
|
Bavachin [CAS 19879-32-4]
|
|
Cancer-programmed cell death
|
|
|
HY-N0233-10mg
|
MedChemexpress LLC
|
Bavachin [CAS 19879-32-4]
|
|
Cancer-programmed cell death
|
|
|
HY-N0233-25mg
|
MedChemexpress LLC
|
Bavachin [CAS 19879-32-4]
|
|
Cancer-programmed cell death
|
|
|
HY-N0233-5mg
|
MedChemexpress LLC
|
Bavachin [CAS 19879-32-4]
|
|
Cancer-programmed cell death
|
|
|
HY-N0233-1mL
|
MedChemexpress LLC
|
Bavachin [CAS 19879-32-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-104000-10mg
|
MedChemexpress LLC
|
BAY-320 [CAS 1445830-50-1]
|
|
Cancer-programmed cell death
|
|
|
HY-104000-100mg
|
MedChemexpress LLC
|
BAY-320 [CAS 1445830-50-1]
|
|
Cancer-programmed cell death
|
|
|
HY-104000-25mg
|
MedChemexpress LLC
|
BAY-320 [CAS 1445830-50-1]
|
|
Cancer-programmed cell death
|
|
|
HY-104000-5mg
|
MedChemexpress LLC
|
BAY-320 [CAS 1445830-50-1]
|
|
Cancer-programmed cell death
|
|
|
HY-104000-50mg
|
MedChemexpress LLC
|
BAY-320 [CAS 1445830-50-1]
|
|
Cancer-programmed cell death
|
|
|
HY-104000-1mL
|
MedChemexpress LLC
|
BAY-320 [CAS 1445830-50-1] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-117727A-5mg
|
MedChemexpress LLC
|
Leriglitazone (hydrochloride) [CAS 146062-46-6]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-14442-5mg
|
MedChemexpress LLC
|
ML 10302 (hydrochloride) [CAS 186826-17-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-R03503A-20nmol
|
MedChemexpress LLC
|
mMu -miR-680 agomir
|
|
|
|
|
HY-R03503A-5nmol
|
MedChemexpress LLC
|
mMu -miR-680 agomir
|
|
|
|
|
HY-RI03503A-20nmol
|
MedChemexpress LLC
|
mMu -miR-680 antagomir
|
|
|
|
|
HY-RI03503A-5nmol
|
MedChemexpress LLC
|
mMu -miR-680 antagomir
|
|
|
|
|
HY-RI03503-20nmol
|
MedChemexpress LLC
|
mMu -miR-680 inhibitor
|
|
|
|
